Serotonin and superior mesenteric artery resistance index

References

• Hansen M. B., Dresner L. S., Wait R. B. Profile of neurohumoral agents on mesenteric and intestinal blood flow in health and disease. Physiol Res 1998; 47: 307–27
   PubMed Web of Science ®Google Scholar
• Da Prada M., Tranzer J. P., Pletscher A. Storage of 5‐hydroxytryptamine in human blood platelets. Experientia 1972; 28: 1328–9
   PubMedGoogle Scholar
• Kalkman H. O., Engel G., Hoyer D. Three distinct subtypes of serotonergic receptors mediate the triphasic blood pressure response to serotonin in rats. J Hypertens 1984; Suppl 2: S143–5
   Google Scholar
• Bearcroft C. P., Perrett D., Farthing M. J. Postprandial plasma 5‐hydroxytryptamine in diarrhoea predominant irritable bowel syndrome: a pilot study. Gut 1998; 42: 42–6
   PubMed Web of Science ®Google Scholar
• Houghton L. A., Atkinson W., Whitaker R. P., Whorwell P. J., Rimmer M. J. Increased platelet depleted plasma 5‐hydroxytryptamine concentration following meal ingestion in symptomatic female subjects with diarrhoea predominant irritable bowel syndrome. Gut 2003; 52: 663–70
   PubMed Web of Science ®Google Scholar
• Atkinson W., Lockhart S. J., Whorwell P., Keevil B. G., Houghton L. A. Altered 5‐hydroxytryptamine signaling in patients with constipation and diarrhoea predominant irritable bowel syndrome. Gastroenterology 2006; 130: 34–43
   PubMed Web of Science ®Google Scholar
• Hansen M. B. The enteric nervous system III: a target for pharmacological treatment. Pharmacol Toxicol 2003; 93: 1–13
   PubMedGoogle Scholar
• Van Zwieten P. A. Pathophysiological relevance of serotonin. J Cardiovasc Pharmacol 1987; 10 Suppl 3: S19–25
   PubMedGoogle Scholar
• Friedel D., Thomas R., Fisher R. S. Ischemic colitis during treatment with alosetron. Gastroenterology 2001; 120: 557–60
   PubMed Web of Science ®Google Scholar
• Mayer E. A., Bradesi S. Alosetron and irritable bowel syndrome. Expert Opin Pharmacother 2003; 4: 2089–98
   PubMed Web of Science ®Google Scholar
• Siegel S., Castellan N. J. Nonparametric statistics for the behavioural sciences. McGraw‐Hill, Boston 1988; 216–22
   Google Scholar
• Sieber C., Beglinger C., Jager K., Stalder G. A. Intestinal phase of superior mesenteric artery blood flow in man. Gut 1992; 33: 497–501
   PubMed Web of Science ®Google Scholar
• Andersen T. C., Pedersen J. F., Nordentoft T., Olsen O. Fat and mesenteric blood flow. Scand. J Gastroenterol 1999; 34: 894–7
   Google Scholar
• Perko M. J. Duplex ultrasound for assessment of superior mesenteric artery blood flow. Eur J Vasc Endovasc Surg 2001; 21: 106–17
   PubMedGoogle Scholar
• Lynch T. G., Hobson R. W., Kerr J. C., Brousseau D. A., Silverman D. G., Reilly C. A., et al. Doppler ultrasound, laser Doppler, and perfusion fluorometry in bowel ischemia. Arch Surg 1988; 123: 483–6
   PubMedGoogle Scholar
• Schmidt P. T., Lordal M., Gazelius B., Hellstrom P. M. Tachykinins potently stimulate human small bowel blood flow: a laser Doppler flowmetry study in humans. Gut 2003; 52: 53–6
   PubMedGoogle Scholar
• Zoli M., Merkel C., Sabba C., Sacerdoti D., Gaiani S., Ferraioli G., et al. Interobserver and inter‐equipment variability of echo‐Doppler sonographic evaluation of the superior mesenteric artery. J Ultrasound Med 1996; 15: 99–106
   PubMedGoogle Scholar
• Spencer J. A., Giussani D. A., Moore P. J., Hanson M. A. In vitro validation of Doppler indices using blood and water. J Ultrasound Med 1991; 10: 305–8
   PubMed Web of Science ®Google Scholar
• Maulik D., Arbeille P., Kadado T. Hemodynamic foundation of umbilical arterial Doppler waveform analysis. Biol Neonate 1992; 62: 280–9
   PubMedGoogle Scholar
• Fenger‐Gron J., Mulvany M. J., Christensen K. L. Intestinal blood flow is controlled by both feed arteries and microcirculatory resistance vessels in freely moving rats. J Physiol 1997; 498: 215–24
   PubMedGoogle Scholar
• Vanner S., MacNaughton W. K. Submucosal secretomotor and vasodilator reflexes. Neurogastroenterol Motil 2004; 16: 39–43
   PubMedGoogle Scholar
• Sieber C., Beglinger C., Jaeger K., Hildebrand P., Stalder G. A. Regulation of postprandial mesenteric blood flow in humans: evidence for a cholinergic nervous reflex. Gut 1991; 32: 361–6
   PubMed Web of Science ®Google Scholar
• Lordal M., Hellstrom P. M. 5‐Hydroxytryptamine: initiator of phase 3 of migrating motor complex. Acta Physiol Scand 1995; 155: 241–2
   PubMedGoogle Scholar
• Banks R. O., Gallavan R. H., Jr., Zinner M. H., Bulkley G. B., Harper S. L., Granger D. N., et al. Vasoactive agents in control of the mesenteric circulation. Fed Proc 1985; 44: 2743–9
   PubMedGoogle Scholar
• Granger N. D., Kvietys P. R., Korthuis R. J., Premen A. J. Microcirculation of the intestinal mucosa. Handbook of physiology The gastrointestinal system, S. G Schultz. American Physiological Society, BethesdaMaryland, USA 1989; 1405–74
   Google Scholar
• Jodal M., Lundgren O. Neurohormonal control of gastrointestinal blood flow. Handbook of physiology. The gastrointestinal system Bethesda, S. G Schultz. American Physiological Society, Maryland, USA 1989; 1617–71
   Google Scholar
• Tsukamoto Y., Goto H., Hase S., Arisawa T., Ohara A., Suzuki T., et al. Serotonin‐induced decrease of duodenal mucosal blood flow plus acid load produces duodenal mucosal lesion in rats. Digestion 1991; 50: 99–103
   PubMedGoogle Scholar
• Fara J. W. Mesenteric vasodilator effect of 5‐hydroxytryptamine: possible enteric neuron mediation. Arch Int Pharmacodyn Ther 1976; 221: 235–49
   PubMedGoogle Scholar
• Fasth S., Hedlund H., Hulten L., Nordgren S., Oresland T. The effects of 5‐hydroxytryptamine on large intestinal motility and blood flow in the cat. Acta Physiol Scand 1983; 118: 329–36
   PubMedGoogle Scholar
• Anderson G. M., Stevenson J. M., Cohen D. J. Steady‐state model for plasma free and platelet serotonin in man. Life Sci 1987; 41: 1777–85
   PubMedGoogle Scholar
• Zinner M. J., Kasher F., Jaffe B. M. The hemodynamic effects of intravenous infusions of serotonin in conscious dogs. J Surg Res 1983; 34: 171–8
   PubMed Web of Science ®Google Scholar
• Rossi P., Andriesse G. I., Oey P. L., Wieneke G. H., Roelofs J. M., Akkermans L. M. Stomach distension increases efferent muscle sympathetic nerve activity and blood pressure in healthy humans. J Neurol Sci 1998; 161: 148–55
   PubMed Web of Science ®Google Scholar
• O'Donovan D., Feinle C., Tonkin A., Horowitz M., Jones K. L. Postprandial hypotension in response to duodenal glucose delivery in healthy older subjects. J Physiol 2002; 540: 673–9
   PubMedGoogle Scholar
• Boeckxstaens G. E., Hirsch D. P., van den Elzen B. D., Heisterkamp S. H., Tytgat G. N. Impaired drinking capacity in patients with functional dyspepsia: relationship with proximal stomach function. Gastroenterology 2001; 121: 1054–63
   PubMed Web of Science ®Google Scholar
• Martin G. R. Vascular receptors for 5‐hydroxytryptamine: distribution, function and classification. Pharmacol Ther 1994; 62: 283–324
   PubMed Web of Science ®Google Scholar
• Su C., Uruno T. Excitatory and inhibitory effects of 5‐hydroxytryptamine in mesenteric arteries of spontaneously hypertensive rats. Eur J Pharmacol 1984; 106: 283–90
   PubMedGoogle Scholar
• Gronstad K. O., Dahlstrom A., Jaffe B. M., Ahlman H. Regional and selective changes in blood flow of the feline small intestine induced by endoluminal serotonin. Acta Physiol Scand 1986; 127: 207–13
   PubMedGoogle Scholar
• Coates M. D., Mahoney C. R., Linden D. R., Sampson J. E., Chen J., Blaszyk H., et al. Molecular defects in mucosal serotonin content and decreased serotonin reuptake transporter in ulcerative colitis and irritable bowel syndrome. Gastroenterology 2004; 126: 1657–64
   PubMed Web of Science ®Google Scholar
• Dunlop S. P., Coleman N. S., Blackshaw E., Perkins A. C., Singh G., Marsden C. A., et al. Abnormalities of 5‐hydroxytryptamine metabolism in irritable bowel syndrome. Clin Gastroenterol Hepatol 2005; 3: 349–57
   PubMed Web of Science ®Google Scholar
• Pata C., Erdal M. E., Derici E., Yazar A., Kanik A., Ulu O. Serotonin transporter gene polymorphism in irritable bowel syndrome. Am J Gastroenterol 2002; 97: 1780–4
   PubMed Web of Science ®Google Scholar
• Galligan J. J. 5‐hydroxytryptamine, ulcerative colitis, and irritable bowel syndrome: molecular connections. Gastroenterology 2004; 126: 1897–9
   PubMedGoogle Scholar
• Hicks G. A., Coldwell J. R., Schindler M., Ward P. A., Jenkins D., Lynn P. A., et al. Excitation of rat colonic afferent fibres by 5‐HT(3) receptors. J Physiol 2002; 544: 861–9
   PubMedGoogle Scholar
• Dalessandri K. M., Lantz B. M., Tsukamoto H., Link D. P., Brock J. Superior mesenteric artery vasoactivity in hyperlipidemic Watanabe rabbits versus normal lipidemic New Zealand controls. J Invest Surg 1989; 2: 471–7
   PubMedGoogle Scholar
• Lopez J. A., Brown B. P., Armstrong M. L., Piegors D. J., Heistad D. D. Response of the mesenteric circulation to serotonin in normal and atherosclerotic monkeys: implications for the pathogenesis of non‐occlusive intestinal ischaemia. Cardiovasc Res 1989; 23: 117–24
   PubMedGoogle Scholar